Private company

Allena Pharmaceuticals, Inc.

Last updated Oct 16, 2026.

Overview

  • IndustryBiological Products, (No Diagnostic Substances)
  • HeadquartersDE
  • Incorporated inDE2
  • Business address142 -F North Road, Suite 150, Sudbury, Ma 017762
  • Filer category, Emerging growth company2

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income34567-$47.6M in 2021+97% since 2016
-$60.0M-$40.0M-$20.0M02016: -$24.2M-$24.2M20162017: -$20.9M-$20.9M2017−13%2018: -$35.6M-$35.6M2018+70%2019: -$47.5M-$47.5M2019+34%2020: -$32.0M-$32.0M2020−33%2021: -$47.6M-$47.6M2021+49%
Net income34567-$48.7M in 2021+242% since 2015
-$60.0M-$40.0M-$20.0M02015: -$14.2M-$14.2M20152016: -$24.5M-$24.5M2016+72%2017: -$21.6M-$21.6M2017−12%2018: -$35.6M-$35.6M2018+65%2019: -$47.3M-$47.3M2019+33%2020: -$32.8M-$32.8M2020−31%2021: -$48.7M-$48.7M2021+48%
Fiscal year20152016201720182019202020212022
Research and development$11.5M3$20.1M4$15.5M5$26.4M6$37.2M7$20.4M7$35.0M7
Operating income-$24.2M3-$20.9M4-$35.6M5-$47.5M6-$32.0M7-$47.6M7
Income tax$05$05$05$06$07
Net income-$14.2M3-$24.5M4-$21.6M5-$35.6M6-$47.3M7-$32.8M7-$48.7M7

Compare Allena Pharmaceuticals, Inc. with another company

Recent filings

  1. Sep 7, 20228-K
  2. Sep 2, 20228-K
  3. Aug 24, 20228-K
  4. Aug 15, 202210-Q
  5. Aug 11, 20228-K
  6. Aug 4, 20228-K
  7. Jul 12, 20228-K
  8. Jul 11, 20228-K
  9. Jul 8, 20228-K
  10. Jul 5, 20228-K
  11. Jun 28, 20228-K
  12. Jun 23, 2022S-1
  13. Jun 22, 20228-K
  14. May 24, 2022DEF 14A
  15. May 16, 202210-Q

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1